Target intelligence / Profile preview

Central nervous system serotonergic pathway

Molecular classification
Other (neural pathway, not a single molecule or protein)
01

Overview

The "Central nervous system serotonergic pathway" refers to a network of neurons in the brain that use serotonin as their neurotransmitter. These pathways originate primarily from clusters called raphe nuclei in the brainstem. The axons from these neurons project widely throughout both cortical and subcortical regions—including areas involved in mood regulation, sensorimotor control, pain inhibition, and cognitive functions. The dorsal and median raphe nuclei are especially important sources for these projections[1][2]. Serotonin acts through multiple receptor families—most notably G protein-coupled receptors—and is involved in diverse physiological processes such as mood regulation, sleep-wake cycles, appetite control, memory formation, sensory processing, and motor activity[1][2][3]. Dysfunction within this system has been implicated in various neuropsychiatric conditions including depression and chronic pain syndromes[1]. Note: This entry is not a single molecular target but rather describes an entire neurotransmitter signaling network composed of many different molecules—primarily various serotonin receptor subtypes (such as 5‑HT₁A or 5‑HT₂A), enzymes for synthesis/degradation (like tryptophan hydroxylase), and transporters like SERT. For structured drug discovery information or therapeutic targeting purposes it is necessary to specify an individual component within this system rather than referring to the entire "central nervous system serotonergic pathway"[3].

Other names
Central serotonergic pathwaySerotonergic system of the central nervous systemCNS serotonergic pathway
02

Biological functions

Signal transductionRegulation of mood and emotionSensorimotor functionModulation of pain perceptionRegulation of sleep, hunger, memory, and learning
03

Disease associations

Neuropsychiatric disorders (e.g., depression)Pain disorders (e.g., migraine, fibromyalgia)Mood disorders

Beyond the preview

Go deeper on Central nervous system serotonergic pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Central nervous system serotonergic pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call